Biblio Discovery — Demo Discovery Service

3 results for "Torsten Trowe"

Showing 1–3 · 2.32 seconds · RSS

  1. Journal Article

    Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants

    Anees M. Dauki; Nishanthan Rajakumaraswamy; Torsten Trowe et al.

    Clinical and Translational Science, Vol. 17 No. 8 · 2024 · English · DOAJ Scopus

    Abstract Conventional dendritic cells subtype 1 (cDC1) play a vital role in the priming and expansion of tumor‐specific CD8+ T cells and their recruitment to tumor microenvironment. However, cDC1s are often underrepresented in the microenvironment. Systemic administration of Fms‐like tyrosine…

  2. Journal Article

    Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells

    Abhishek Aggarwal; Pamela M. Odorizzi; Jens Brodbeck et al.

    JHEP Reports, Vol. 5 No. 4 · 2023 · English · DOAJ Scopus

    Background & Aims: Patterns of liver HBV antigen expression have been described but not quantified at single-cell resolution. We applied quantitative techniques to liver biopsies from individuals with chronic hepatitis B and evaluated sampling heterogeneity, effects of disease stage, and…

  3. Journal Article

    SMG1, a nonsense‐mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma

    Alexander C. Leeksma; Ingrid A. M. Derks; Brett Garrick et al.

    Molecular Oncology, Vol. 17 No. 2 · 2023 · English · DOAJ Scopus

    Early data suggested that CC‐115, a clinical molecule, already known to inhibit the mammalian target of rapamycin kinase (TORK) and DNA‐dependent protein kinase (DNA‐PK) may have additional targets beyond TORK and DNA‐PK. Therefore, we aimed to identify such target(s) and investigate a potential…